N4BP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.440000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.243200E-01
Normal-vs-Stage2
3.169200E-01
Normal-vs-Stage3
2.090000E-01
Normal-vs-Stage4
8.010000E-01
Stage1-vs-Stage2
4.304600E-01
Stage1-vs-Stage3
1.658400E-01
Stage1-vs-Stage4
4.669400E-01
Stage2-vs-Stage3
3.715200E-01
Stage2-vs-Stage4
9.692200E-02
Stage3-vs-Stage4
1.268440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.699200E-01
Normal-vs-AfricanAmerican
8.109400E-01
Normal-vs-Asian
8.948500E-02
Caucasian-vs-AfricanAmerican
6.608800E-01
Caucasian-vs-Asian
1.592370E-01
AfricanAmerican-vs-Asian
9.074300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.690200E-01
Normal-vs-Female
5.199400E-01
Male-vs-Female
7.722200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.952200E-01
Normal-vs-Age(41-60Yrs)
6.662400E-01
Normal-vs-Age(61-80Yrs)
5.527000E-01
Normal-vs-Age(81-100Yrs)
1.005400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.708800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.625800E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.134760E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.858200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.714300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.141380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.730030E-01
Normal-vs-Daily Drinker
5.400000E-02
Normal-vs-Weekly Drinker
1.486770E-01
Normal-vs-Occasional Drinker
4.357800E-01
Normal-vs-Social Drinker
9.557800E-01
Non Drinker-vs-Daily Drinker
1.873980E-01
Non Drinker-vs-Weekly Drinker
7.177400E-01
Non Drinker-vs-Occasional Drinker
3.666000E-01
Non Drinker-vs-Social Drinker
2.053400E-01
Daily Drinker-vs-Weekly Drinker
4.312400E-01
Daily Drinker-vs-Occasional Drinker
5.285900E-02
Daily Drinker-vs-Social Drinker
7.414300E-02
Weekly Drinker-vs-Occasional Drinker
2.899400E-01
Weekly Drinker-vs-Social Drinker
1.616390E-01
Occasional Drinker-vs-Social Drinker
4.286600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.587000E-01
Normal-vs-Grade 2
1.290250E-01
Normal-vs-Grade 3
8.678000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.350440E-01
Grade 1-vs-Grade 3
3.869000E-01
Grade 1-vs-Grade 4
3.587000E-01
Grade 2-vs-Grade 3
8.148000E-02
Grade 2-vs-Grade 4
1.290250E-01
Grade 3-vs-Grade 4
8.678000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.813580E-01
Normal-vs-NonDiabetic
5.090800E-01
Diabetic-vs-NonDiabetic
6.708000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.908000E-01
Normal-vs-NoPancreatitis
5.342200E-01
Pancreatitis-vs-NoPancreatitis
4.261100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.145000E-01
Normal-vs-N1
3.385000E-01
N0-vs-N1
4.115400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.341800E-01
Normal-vs-TP53-NonMutant
9.530600E-01
TP53-Mutant-vs-TP53-NonMutant
8.850400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
